PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
33.69%
Some net income increase while AVGO is negative at -6.77%. John Neff would see a short-term edge over the struggling competitor.
10.20%
D&A growth well above AVGO's 0.31%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-1302.33%
Negative yoy deferred tax while AVGO stands at 1000.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
17.76%
SBC growth well above AVGO's 0.63%. Michael Burry would flag major dilution risk vs. competitor’s approach.
396.52%
Well above AVGO's 46.21% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-317.78%
Both yoy AR lines negative, with AVGO at -19.08%. Martin Whitman would suspect an overall sector lean approach or softer demand.
274.29%
Inventory growth well above AVGO's 384.21%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-30.00%
Negative yoy AP while AVGO is 168.29%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
3533.33%
Growth well above AVGO's 150.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-16.67%
Negative yoy while AVGO is 938.46%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
17.37%
Operating cash flow growth similar to AVGO's 17.27%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-502.90%
Negative yoy CapEx while AVGO is 11.67%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.59%
We have some liquidation growth while AVGO is negative at -638.89%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-99.44%
Both yoy lines negative, with AVGO at -97.30%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-108.39%
We reduce yoy invests while AVGO stands at 32.18%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
85.48%
Debt repayment growth of 85.48% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
76.82%
Similar buyback growth to AVGO's 71.67%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.